Surveillance of Pancreatic Health After Diabetes Diagnosis
A trial with no phase registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 5000 participants.
Also called NCT06803771
- Study
- In this atlas
Overview
- Design
- Interventional study; allocation not applicable; no masking; primary purpose diagnostic
- Phase
- Not applicable
- Enrolled
- 5,000 participants
- Registry
-
NCT06803771
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- United Kingdom
- Registry status
- Recruiting
Technical summary
Registry record NCT06803771. Allocation not applicable; no masking; primary purpose diagnostic. Start 2025-05-21 (actual); primary completion 2029-07-29 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Surveillance of Pancreatic Health After Diabetes Diagnosis
- Acronym
- SAFE-D
- Condition
- Diabetes Mellitus
- Condition
- Pancreatic Cancer, Adult
- Intervention (Device)
- Avantect Pancreatic Cancer Test
- Lead sponsor
- University Hospital Southampton NHS Foundation Trust
- Collaborator
- ClearNote Health
Record details
- Record id
cardio:ct-nct06803771- Content hash
25998921cc7a1fd8f779cb862942daa7673a7843aebc1a8acab105ffeaac8fde